<p>Animal body mass (g) were recorded every two days for 10 days as a measure of fold change from day 0, pellet surgery (A). Animal body mass on day 10 was measured as a percent change of body mass from day 0 (B). The dotted line (100%) represents no change in body mass from day 0. Arrow indicates that 2 days after pellet surgeries respective antagonists or vehicle were administered at 80 mg/kg/day to each treatment group. Bars that do not share similar letters denote statistical significance, p<0.05, one-way ANOVA using Tukey's post-hoc test. n = 7–10. All values are means ± SE.</p
<p>A. Weight averages on the first day of ASR testing, which is also the first day post-exposure. B....
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>The change in mean body weight after tolvaptan therapy is shown over time. The solid line represe...
<p>Small x indicates significant differences from all treatments; asterisks and horizontal lines ind...
1<p>Daily body weight for each individual animal from study start until death was evaluated and trea...
<p>(<sup>#</sup>p = 0.0153 compared to control, * p = 0.0153 compared to ATV and SQV, respectively)....
<p>(***p<0.0001 compared to normal control, #p<0.0001 compared to non-treated STZ group).</p
<p>Post-challenge body weights are presented as mean % body weight by taking the body weight of indi...
<p>Effects by fourth i.c.v. drug treatment on body weight changes (mean g ± SE). (A) The animals rec...
<p>Body weights were determined at the start and end of treatment. Heart weights were determined at ...
<p>Animals' body weight and liver mass at the beginning and at the end of the experiment.</p
<p>Body weight was measured twice a week. Graph indicates average percent of initial body weight an...
<p>Percentage weight change was calculated by comparing the pre-infection body weight to daily p.i b...
<p>B. Body weight change (% of the beginning body weight) during the treatment. One way ANOVA Dunnet...
<p><b>Effect of treatments on body weight.</b> (<b>A</b>) <i>mdx</i> mice received no treatment (N =...
<p>A. Weight averages on the first day of ASR testing, which is also the first day post-exposure. B....
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>The change in mean body weight after tolvaptan therapy is shown over time. The solid line represe...
<p>Small x indicates significant differences from all treatments; asterisks and horizontal lines ind...
1<p>Daily body weight for each individual animal from study start until death was evaluated and trea...
<p>(<sup>#</sup>p = 0.0153 compared to control, * p = 0.0153 compared to ATV and SQV, respectively)....
<p>(***p<0.0001 compared to normal control, #p<0.0001 compared to non-treated STZ group).</p
<p>Post-challenge body weights are presented as mean % body weight by taking the body weight of indi...
<p>Effects by fourth i.c.v. drug treatment on body weight changes (mean g ± SE). (A) The animals rec...
<p>Body weights were determined at the start and end of treatment. Heart weights were determined at ...
<p>Animals' body weight and liver mass at the beginning and at the end of the experiment.</p
<p>Body weight was measured twice a week. Graph indicates average percent of initial body weight an...
<p>Percentage weight change was calculated by comparing the pre-infection body weight to daily p.i b...
<p>B. Body weight change (% of the beginning body weight) during the treatment. One way ANOVA Dunnet...
<p><b>Effect of treatments on body weight.</b> (<b>A</b>) <i>mdx</i> mice received no treatment (N =...
<p>A. Weight averages on the first day of ASR testing, which is also the first day post-exposure. B....
<p>SNU-16 stomach tumor-bearing mice that were analyzed for imaging signals after the first and seco...
<p>The change in mean body weight after tolvaptan therapy is shown over time. The solid line represe...